Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy

[摘要] Etanercept and other anti-TNF-alpha agents have been indicated as a therapeutic option in severe drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Etanercept has been shown to quickly reduce the detachment of the epidermis and shorten healing time. Cases of etanercept-induced severe adverse drug reactions were also described.

[学科分类] 皮肤病学

[关键词] adalimumab;adverse reactions;golimumab;infliximab;tumor necrosis factor